Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression. (Q40635375)
Jump to navigation
Jump to search
scientific article published on 11 September 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression. |
scientific article published on 11 September 2003 |
Statements
Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression (English)
Pankaj Trivedi
Kumi Takazawa
Claudia Zompetta
Laura Cuomo
Elena Anastasiadou
Stefania Uccini
Kenzo Takada
Luigi Frati
Alberto Faggioni
11 September 2003